Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.

Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.

Bibliografske podrobnosti
Main Authors:	Danesh, J, Lewington, S
Format:	Journal article
Jezik:	English
Izdano:	1998

Podobne knjige/članki

Homocysteine and coronary heart disease.
od: Clarke, R, et al.
Izdano: (2002)

Homocysteine and prediction of coronary heart disease and stroke
od: Clarke, R, et al.
Izdano: (2003)

Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
od: Clarke, R, et al.
Izdano: (2011)

Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
od: Clarke, R, et al.
Izdano: (2011)

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
od: Den Heijer, M, et al.
Izdano: (2005)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
od: Holman, R, et al.
Izdano: (2001)

Homocysteine and Risk of Premature Coronary Heart Disease
od: Lutfi Zylbeari, et al.
Izdano: (2020-07-01)

Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.
od: Huxley, R, et al.
Izdano: (2002)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
od: Clarke, R, et al.
Izdano: (2007)

Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
od: Clarke, R
Izdano: (2002)

Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
od: Clarke, R, et al.
Izdano: (2001)

Homocysteine, Β Vitamins and Immune Activation in Coronary Heart Disease
od: Frick Barbara, et al.
Izdano: (2003-08-01)

Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
od: Clarke, R, et al.
Izdano: (2012)

Homocysteine, renal function, and risk of cardiovascular disease.
od: Clarke, R, et al.
Izdano: (2003)

Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studies.
od: Whitlock, G, et al.
Izdano: (2002)

CORRELATION BETWEEN TOTAL PLASMA HOMOCYSTEINE LEVEL AND GRADING OF CORONARY ARTERY DISEASE
od: S. J. Mirhoseini, et al.
Izdano: (2008-05-01)

CORRELATION BETWEEN TOTAL PLASMA HOMOCYSTEINE LEVEL AND GRADING OF CORONARY ARTERY DISEASE
od: S. J. Mirhoseini, et al.
Izdano: (2008-04-01)

Homocysteine levels and risk of essential hypertension: A meta-analysis of published epidemiological studies
od: Fade Zhong, et al.
Izdano: (2017-02-01)

Effect of garlic on plasma homocysteine level in ischemic heart disease patients
od: Mohadeseh Sadat Mousavian, et al.
Izdano: (2017-04-01)

Plasma Homocysteine and Vascular Disease
od: Kelly M Elian
Izdano: (2020-12-01)

Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
od: Robert Clarke, et al.
Izdano: (2012-02-01)

Comparing the sensitivity of pyridoxal-5-phosphate, homocysteine and neopterin in coronary heart disease
od: Rudzite Vera, et al.
Izdano: (2002-08-01)

Factors determining homocysteine levels in Russian patients with stable coronary heart disease
od: O. O. Shakhmatova, et al.
Izdano: (2010-08-01)

Homocysteine and risk of cardiovascular disease and venous thrombosis
od: Clarke, R, et al.
Izdano: (2003)

MTRR rs326119 polymorphism is associated with plasma concentrations of homocysteine and cobalamin, but not with congenital heart disease or coronary atherosclerosis in Brazilian patients
od: Melanie Horita, et al.
Izdano: (2017-03-01)

Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.
od: Lowe, G, et al.
Izdano: (2004)

Trans fatty acids and coronary heart disease.
od: Clarke, R, et al.
Izdano: (2006)

The importance of cholesterol, blood pressure and smoking for coronary heart disease.
od: Lewington, S
Izdano: (2003)

Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease
od: Zhixin Zhang, et al.
Izdano: (2022-05-01)

Blood pressure and coronary heart disease: a review of the evidence.
od: Lawes, C, et al.
Izdano: (2002)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
od: Nurk, E, et al.
Izdano: (2005)

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease.
od: van Meurs, J, et al.
Izdano: (2013)

Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk.
od: Ghassibe-Sabbagh, M, et al.
Izdano: (2012)

Genetic and environmental influences on total plasma homocysteine and its role in coronary artery disease risk
od: Ghassibe-Sabbagh, M, et al.
Izdano: (2012)

Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
od: Emanuele Di Angelantonio, et al.
Izdano: (2007-09-01)

Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis.
od: Danesh, J, et al.
Izdano: (2002)

Effect of Homocysteine on the Cardiac Function and Coronary Flow in the Isolated Heart of Rat
od: Daryoosh Shackebaei, et al.
Izdano: (2007-09-01)

Stroke, coronary heart disease, cholesterol and blood pressure
od: Lewington, S, et al.
Izdano: (1997)

Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects
od: Ling Wenhua, et al.
Izdano: (2011-08-01)

Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
od: Clarke, R, et al.
Izdano: (2007)